Home Search
cancer - search results
If you're not happy with the results, please do another search
New Cancer Research UK manifesto aims to avoid 20,000 UK cancer deaths per year
Cancer Research UK has launched a new manifesto urging the next UK Government to take action to prevent 20,000 avoidable UK cancer deaths annually...
AccuTOX® anticancer drug demonstrates exciting antigen cross-presentation
Defence Therapeutics Inc., a prominent Canadian biopharmaceutical company renowned for its work in immune-oncology vaccines and drug delivery technologies, has announced the discovery of...
Defence Therapeutics Inc. releases Accum® study revealing its anti-cancer properties
Defence Therapeutics Inc. have announced the publication of a peer-reviewed study on the anti-cancer properties of its unconjugated Accum®.
Researchers discover new target to combat cancer drug resistance
In a groundbreaking development, scientists at the University of Queensland have pinpointed a novel drug target with immense promise in combating cancer drug resistance...
How Defence’s Accum® technology is advancing cancer therapeutics
Industry-leading biotechnology pioneer Defence Therapeutics details how the company is advancing immune oncology through its revolutionary Accum® technology.
Whether using an antibody, cell-based vaccine or...
AI breast cancer screening is safe and detects 20% more cancers
Lund University research suggests that AI breast cancer screening is a safe alternative to traditional screening, identifies more cancer cases, and is more efficient.
The...
UK and BioNTech SE sign landmark deal for cancer vaccine trials
The UK Government has established a historic agreement with German-based BioNTech SE for cancer vaccine trials.
The groundbreaking deal will improve access to cancer vaccine...
Defence Therapeutics initiate testing of ARM vaccine against pancreatic cancer
Defence Therapeutics has mandated the Transbiotech Biotechnology Research and Transfer Center to begin testing its cellular anti-cancer ARM vaccine against pancreatic cancer.
Research from the...
Pioneering approaches to gynaecological cancer diagnostics
Lorna Rothery spoke to Marina Rigau, CEO and Co-Founder of EIT Health-supported start-up MiMARK, about the challenges associated with the diagnosis of gynaecological conditions.
By...
Striving for more in cancer care and prevention
Despite vast improvements in cancer care, challenges remain in driving forward cancer prevention strategies.
Defence Therapeutics’ mRNA cancer vaccine testing begins
Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started.
The performance of Defence’s AccumTM mRNA cancer...
Defence Therapeutics successfully develops ACCUMTM -mRNA cancer vaccine
Canadian biopharmaceutical pioneer Defence Therapeutics has revealed it has successfully conjugated mRNA molecules to AccumTM – a significant breakthrough that looks to enhance the...
Defence to perform final AccuTOXTM preclinical study before Phase I cancer trial
Defence Therapeutics has announced it is performing a final preclinical study to validate the efficacy of AccuTOXTM combined with immune-checkpoint inhibitors before initiating a...
The importance of sex differences in pancreatic cancer treatment
Researchers from Karolinska Institutet have found that certain immune cells in women with pancreatic cancer can obstruct their immune response.
The findings may explain differences...
Delaying treatment for prostate cancer does affect survival rates
According to a new study from the universities of Bristol and Oxford, delaying treatment for prostate cancer does not increase the risk of mortality.
The...
New AI method for diagnosing prostate cancer begins trial in Oxford
An Artificial Intelligence (AI) software that helps with diagnosing prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.
Researchers...
New bone cancer treatment could save children’s lives
Researchers at the University of East Anglia and The University of Sheffield have developed a new bone cancer treatment for children.
Currently, bone cancer treatment...
Researchers have developed a revolutionary new bone cancer treatment
Researchers from the University of East Anglia (UEA) have developed a new, non-invasive bone cancer treatment that is effective against all primary forms of...
UK lung cancer death rates are predicted to fall in 2023
A new study by the University of Milan has found that cancer death rates will fall by 6.5% in men and 3.7% in women.
A...
Genetic link discovered between Duchenne muscular dystrophy and cancer
Researchers from the University of Portsmouth have identified a novel genetic link between Duchenne muscular dystrophy and cancer.
The muscle-wasting disease Duchenne muscular dystrophy is...